Metagenomics Analysis of Breast Microbiome Highlights the Abundance of Rothia Genus in Tumor Tissues/Experiment 1

From BugSigDB


Needs review

Curated date: 2025/07/10

Curator: Ecsharp

Revision editor(s): Ecsharp

Subjects

Location of subjects
Morocco
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Breast Mamma,Mammary part of chest,Mammary region,Breast,breast
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Breast cancer breast cancer,breast tumor,cancer of breast,malignant breast neoplasm,malignant breast tumor,malignant neoplasm of breast,malignant neoplasm of the breast,malignant tumor of breast,malignant tumor of the breast,mammary cancer,mammary neoplasm,mammary tumor,primary breast cancer,Breast cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Adjacent normal tissue of BC patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
Tumor tissue of BC patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breast cancer (BC) patients were pathologically diagnosed with primary BC and underwent surgery for a total or partial mastectomy. Tumor tissue samples were obtained from the cores of tumor tissues without any contamination of normal tissues.
Group 0 sample size Number of subjects in the control (unexposed) group
47
Group 1 sample size Number of subjects in the case (exposed) group
47
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Needs review

Curated date: 2025/07/10

Curator: Ecsharp

Revision editor(s): Ecsharp

Source: Figure 1 (C)

Description: Significant biomarkers between the tumor and adjacent tissues performed by linear discriminant analysis effect size (LEfSe) scores.

Abundance in Group 1: increased abundance in Tumor tissue of BC patients

NCBI Quality ControlLinks
Rothia
Finegoldia
Peptostreptococcales_TissierellalesPeptostreptococcales_Tissierellales

Revision editor(s): Ecsharp

Signature 2

Needs review

Curated date: 2025/07/10

Curator: Ecsharp

Revision editor(s): Ecsharp

Source: Figure 1 (C)

Description: Significant biomarkers between the tumor and adjacent tissues performed by linear discriminant analysis effect size (LEfSe) scores.

Abundance in Group 1: decreased abundance in Tumor tissue of BC patients

NCBI Quality ControlLinks
Pseudomonadaceae
Pseudomonas

Revision editor(s): Ecsharp